FERROSIG

This brand name is authorized in Australia, New Zealand

Active ingredients

The drug FERROSIG contains one active pharmaceutical ingredient (API):

1 Iron polymaltose UNII UM5219H89V - IRON POLYMALTOSE
Read about Iron polymaltose

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B03AC	Iron trivalent, parenteral preparations	B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations
Discover more medicines within B03AC

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 2593L, 2805P
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 11077

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.